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Summary
Activation of the hypoxia-inducible factor (HIF) pathway is a critical step in the transcriptional response to hypoxia. Although many of
the key proteins involved have been characterised, the dynamics of their interactions in generating this response remain unclear. In the
present study, we have generated a comprehensive mathematical model of the HIF-1a pathway based on core validated components and
dynamic experimental data, and confirm the previously described connections within the predicted network topology. Our model
confirms previous work demonstrating that the steps leading to optimal HIF-1a transcriptional activity require sequential inhibition of
both prolyl- and asparaginyl-hydroxylases. We predict from our model (and confirm experimentally) that there is residual activity of the
asparaginyl-hydroxylase FIH (factor inhibiting HIF) at low oxygen tension. Furthermore, silencing FIH under conditions where prolyl-
hydroxylases are inhibited results in increased HIF-1a transcriptional activity, but paradoxically decreases HIF-1a stability. Using a core
module of the HIF network and mathematical proof supported by experimental data, we propose that asparaginyl hydroxylation confers
a degree of resistance upon HIF-1a to proteosomal degradation. Thus, through in vitro experimental data and in silico predictions, we
provide a comprehensive model of the dynamic regulation of HIF-1a transcriptional activity by hydroxylases and use its predictive and
adaptive properties to explain counter-intuitive biological observations.
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Introduction
Hypoxia induces a number of metabolic changes with rapid and
profound consequences for cell physiology (Semenza, 2012). The
regulation of oxygen homeostasis is a tightly controlled cellular
process dependent on the master regulator HIF (hypoxia
inducible factor) (Pouysse´gur et al., 2006; Semenza, 2012)
which upregulates adaptive genes by binding to hypoxia response
elements (HRE) in their promoters (Semenza, 2003). HIF is
composed of an oxygen-regulated a-subunit (HIF-1a, HIF-2a
and HIF-3a) and a constitutively expressed nuclear b-subunit
(HIF-1b). In normoxia, HIF-1a protein levels are low, due to the
action of oxygen-sensitive prolyl hydroxylases (PHDs), which
hydroxylate HIF-1a at Pro-402 and/or Pro-564 (Schofield and
Ratcliffe, 2004) and target it for ubiquitination-dependent
degradation via the Von Hippel-Landau (VHL) protein (Bruick
and McKnight, 2001; Epstein et al., 2001). Another level of
control lies with the oxygen-sensitive asparaginyl hydroxylase
FIH (factor inhibiting HIF), which hydroxylates HIF-1a at Asn-
803 and inhibits the recruitment of the transcriptional co-
activators p300 and CBP (Ebert and Bunn, 1998; Mahon et al.,
2001; Lando et al., 2002; McNeill et al., 2002). In hypoxia,
hydroxylase activity decreases, thus enabling HIF-1a to escape
degradation and inactivation, translocate to the nucleus to form a
transcriptional complex with the HIF1b/ARNT subunit and
transcriptional co-activators and initiate gene expression to
mount an effective, transcriptionally driven adaptive hypoxic
response.
While many of the molecular components of the HIF pathway
have been identified and characterized, the dynamics of their
interaction within the network are less well understood. Knowing
the components of the network is not, in itself, sufficient to
understand the complexity of the system. A systems-level model
of the HIF pathway will provide a dynamic and mechanistic
understanding of how the physical and chemical processes
interact to produce a complex cellular response to hypoxia, by
suggesting explanations based on biologically plausible
mechanisms and making experimentally testable predictions
(Arkin and Schaffer, 2011). To this end, a number of
mathematical models have been proposed for HIF signaling
(Kohn et al., 2004; Kooner et al., 2005; Qutub and Popel, 2006;
Yu et al., 2007; Dayan et al., 2009; Schmierer et al., 2010). Kohn
and colleagues developed the first theoretical model of the HIF
network, which led to a hypothesis that HIF activity behaves in a
sharp switch-like manner in response to decreasing gradient of
oxygen levels (Kohn et al., 2004). Subsequent models have
verified this hypothesis and have provided quantitative
explanations of the mechanism responsible for such switching
behaviour (Qutub and Popel, 2006; Yu et al., 2007). These
models were largely based on experimental data at steady state
level, and have generally not considered the dynamics of the
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hypoxic response due to limitations in the availability of
experimental data. Moreover, early models considered only
PHD as the oxygen sensor in the HIF network and thus
incompletely described regulation of HIF transcriptional
activity. More recent models include FIH but were used to
explore other features of the network such as the regulation of
specific sets of HIF dependent genes (Dayan et al., 2009;
Schmierer et al., 2010).
In this study, we have used a combination of mathematical and
experimental analysis to understand the HIF-1a signalling
network. This is achieved by constructing an iterative dynamic
model which is validated by in-house experimental data and which
has sufficient predictive power to accurately model the HIF
transcriptional response to hypoxia both spatially and temporally.
This model incorporates both PHD and FIH as major regulators of
HIF-1a activity. It also considers cell compartmentalisation and
feedback regulation which were lacking in previous models. In
addition to manipulating the oxygen tension, we have used the
pharmacological inhibitors dimethyloxalylglycine (DMOG) and
JNJ-42041935 (abbreviated to JNJ1935 in this study), both of
which are cell permeable 2-oxoglutarate analogues which inhibit
the hydroxylation of HIF-1a by displacing the endogenous 2-
oxoglutarate cosubstrate required by PHDs and FIH (Mole et al.,
2003; Barrett et al., 2011). Importantly, JNJ1935 is a more potent
and selective inhibitor of PHDs than FIH (Barrett et al., 2011), thus
enabling the pharmacologic dissection of the activities of PHDs
and FIH. Furthermore, the model captures the temporal dynamics
of HIF transcriptional activity in response to hypoxia or to
pharmacological inhibitors through the use of a secreted Gaussia
luciferase reporter under the control of HIF (Bruning et al., 2012).
Thus, employing a systems approach of iterative experimentation
and mathematical modelling, we have developed a spatiotemporal
model of the HIF-1a signalling network which accurately predicts
biological behaviour and have used this model to generate testable
hypotheses. The model can distinguish between prolyl and
asparaginyl hydroxylation and predicts that HIF-1a protein
stabilisation does not always correlate with HIF transcriptional
activity. Instead, the removal of the asparaginyl hydroxylation step
is necessary for HIF-1a activity. Furthermore, through sensitivity-
analysis of the model and qualitative analysis of the coremodule, we
propose that asparaginyl hydroxylation confers upon HIF-1a
resistance to proteosomal degradation. Using a combination of in
vitro experimentation and in silico predictions, we confirm the
network topology of the hypoxia response, establish the wirings
controlling the dynamic regulation of HIF-1a transcriptional activity
by hydroxylases and use the model to offer biologically plausible
explanations to counter-intuitive experimental observations.
Results
A dynamic, mathematical model of the HIF-1a signalling
pathway
To provide a quantitative framework for understanding the HIF
pathway, we have developed a dynamic, ordinary differential
equations-based model from the validated and published core
components of the HIF-1a network (Fig. 1). This model integrates
our current understanding of the interactions between the known
Fig. 1. Proposed scheme of the HIF-1a signalling pathway incorporating prolyl- and asparaginyl-hydroxylation. The different steps of the HIF signalling
pathway are described by mass-action and Michaelis–Menten reactions numbered in red. HIF-1a protein is translated (1), which can be either lost through protein
turnover (2), asparaginyl-hydroxylated (aOH) by Factor Inhibiting HIF (FIH; 5) and/or prolyl-hydroxylated (pOH) by prolyl-hydroxylases (PHD) (3, 7) and
targeted for Von Hippel-Lindau (VHL)-mediated degradation (4, 8). In hypoxia, PHD is inactivated, leading to HIFa protein stabilisation (unhydroxylated or
asparaginyl-hydroxylated form) and translocation to the nucleus (9, 13). HIF-1a can also be exported out (10, 14). Nuclear unhydroxylated HIF-1a can be
asparaginyl-hydroxylated by nuclear FIH (17) and/or prolyl-hydroxylated by nuclear PHD (15, 19) and targeted for nuclear VHL-mediated degradation (16, 20).
PHD is assumed to translocate in (11) and out (12) of the nucleus. If no hydroxylation occurs, nuclear HIF-1a can dimerise with HIF-1b (21), creating a
transcriptional complex (HIFd) which can bind to HIF-response elements (HRE) of the Gaussia luciferase (22), and initiate mRNA transcription (23). Gaussia
mRNA can be translated into Gaussia protein (27) or degraded (26). Gaussia protein can be secreted out of the cell (29) or degraded (28). HIF-1a/b dimer can also
bind to the HRE of PHD, leading to upregulation of PHD protein (24), which is assumed to be the negative feedback to the system, or be degraded through protein
turnover (25).
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HIF-1a pathway components. The readout of the HIF-1a
transcriptional activity used in our model is from the Gaussia
luciferase reporter under the control of HIF (Bruning et al., 2012).
Our model-based study follows an integrated cycle of model-driven
hypothesis generation and experimental validation strategy which
has not previously been reported for the HIF pathway.
Model assumptions
The dynamic model incorporates key molecular interactions in
the HIF-1a pathway and the molecular components and steps of
the model are described in Fig. 1. Detailed discussion of the
model including reactions, reaction rates and parameters are
given in the Materials and Methods and in supplementary
material Tables S1–S3. In normoxia, HIF-1a mRNA and protein
are produced at a steady rate, but the protein is degraded by either
non-specific protein turnover or by the oxygen-sensitive prolyl-
hydroxylation, leading to Von Hippel-Lindau (VHL)-mediated
proteosomal degradation (Kaelin, 2005). Since prolyl-
hydroxylated HIF-1a protein is quickly ubiquitinated by VHL,
we assume the prolyl-hydroxylation step is irreversible (Chan
et al., 2005). Although the PHD isoforms have specific
cytoplasmic or nuclear localisation (Metzen et al., 2003), they
are considered as one entity for simplicity, and are assumed to be
present in both compartments. HIF can also be inactivated by FIH
through asparaginyl-hydroxylation (Mahon et al., 2001; Lando
et al., 2002). Since FIH was also found in both compartments but
mainly in the cytoplasm (Metzen et al., 2003), our model assumes
a higher level of FIH in the cytoplasm than in the nucleus. We
also assume that HIF-1a hydroxylation mediated by PHD and
FIH as well as VHL-induced HIF degradation can occur in both
cytoplasmic and nuclear compartments with comparable kinetics.
We assume that asparaginyl-hydroxylated HIF-1a can be
subsequently prolyl-hydroxylated, but prolyl-hydroxylated HIF
is unlikely to be subsequently asparaginyl-hydroxylated due to
the rapid VHL-mediated degradation of prolyl-hydroxylated HIF-
1a (Chan et al., 2005). The hydroxylation steps are assumed to be
mostly irreversible, although a small fraction could in theory be
dehydroxylated (Lancaster et al., 2004).
Hydroxylated or unhydroxylated HIF-1a protein is also
assumed to shuttle to the nucleus via the importin pathway
(Depping et al., 2008). In the nucleus, unhydroxylated HIF-1a
can dimerise with HIF-1b to form a transcriptional complex
(Jiang et al., 1996). We did not include a separate step for the
binding to the transcriptional co-activators p300/CBP and assume
that the formation of the HIFa/b dimer results in a
transcriptionally active complex. This complex can bind to
hypoxia response elements (HRE) in the promoter region of
hypoxia-responsive genes, such as those on the Gaussia reporter
gene which is used to assay temporal HIF transcriptional activity
(Bruning et al., 2012), and upregulate their expression. A
negative feedback loop consisting of an upregulation of the
HIF-regulated PHD (Marxsen et al., 2004; Stiehl et al., 2006;
Minamishima et al., 2009) is also included. Furthermore, as
PHDs are induced by hypoxia (Stiehl et al., 2006) and their levels
can change dynamically, we assume PHDs can translocate in and
out of the nucleus (Jokilehto et al., 2006; Steinhoff et al., 2009;
Pientka et al., 2012).
HIF protein stabilisation and transcriptional activity in
hypoxia
HIF activation is well characterised in cells exposed to hypoxia
(Semenza, 2006). Densitometric analysis of HIF-1a western blots
show that the HIF protein was rapidly and transiently stabilised at
3% and more at 1% oxygen tensions (Fig. 2A,B), resulting in a
corresponding HIF-1a transcriptional activity as measured in
human embryonic kidney cells (HEK293) transfected with
pGluc-HRE (Fig. 2C). No activity was detected in normoxia
(21% oxygen tension). Thus we confirm previous studies
demonstrating that HIF protein is stabilised in low oxygen
tension, resulting in the corresponding transcriptional activity as
reported by pGluc-HRE.
No obvious stabilisation of HIF-2a was observed in HEK293
cells in response to hypoxia over 12 hours (supplementary
material Fig. S1). Therefore, in this model, the vast majority of
the HIF-dependent transcriptional effects can be ascribed to the
HIF-1 isoform. The HIF-1a stabilisation and transcriptional
activity data was fitted to the HIF-1a model to estimate model
parameters (supplementary material Table S3). Detailed
discussion of the calibration of the model to oxygen level is
given in the Materials and Methods. Fig. 2D shows simulations
Fig. 2. HIF-1a stabilisation and transcriptional activity is
dependent on oxygen tension. (A) Hypoxia induces
stabilisation of HIF-1a in HEK293 cells cultured under
hypoxic conditions (1% and 3% O2) (n55 per group).
(B) Densitometric analysis of the HIF-1a western blots.
(C) Relative luciferase activity from HEK293 cells
transfected with HRE-pGluc plasmid and cultured under
different oxygen tension [21% O2 (blue, n525); 3% O2 (red,
n56) and 1% O2 (black, n517)]. (D) Simulations of the HIF-
1a transcriptional activity at 21% O2 (blue); 3% O2 (red) and
1% O2 (black). RLU, relative luciferase units.
Journal of Cell Science 126 (6)1456
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for the HIF-1a transcriptional activity in 21%, 3% and 1%
oxygen which closely matched the experimental data (Fig. 2C cf.
2D). Thus our model can accurately predict HIF-1a
transcriptional activity when the oxygen tension is changed.
HIF-1a stabilisation and activity following hydroxylase
inhibition
A prediction of the model is that inhibition of both PHD and FIH
are required for optimal HIF-1a-dependent transcriptional activity.
The percentage of active PHD and FIH is decreased in the model to
reflect an inhibition of either PHD alone or both PHD and FIH.
Simulations for HIF stabilisation and transcriptional activity under
these conditions are shown in Fig. 3A–D. The model predicts that
HIF stabilisation is dependent on the abundance of active PHD
(Fig. 3A,B) and that a reduction in active FIH is needed in order to
observe a corresponding increase in HIF-1a transcriptional activity
(Fig. 3C,D).
To test these predictions, we use two different hydroxylase
inhibitors: DMOG, a pan-hydroxylase inhibitor; and JNJ-42041935,
a prolyl-hydroxylase selective inhibitor (abbreviated to JNJ1935 in
this paper). Low concentrations of JNJ1935 were previously shown
to selectively inhibit PHDs, whereas higher concentrations inhibit
all hydroxylases, including FIH (Barrett et al., 2011). For both
inhibitors, we observed a dose-dependent and time-dependent
stabilisation of HIF-1a protein (Fig. 3E). Densitometric analysis of
the HIF-1a western blots show that 100 mM JNJ1935 stabilised
HIF-1a at the same level as 1 mM DMOG in stabilising HIF after
12 hours (Fig. 3F,G). Consistent with the model prediction of PHD
and FIH inhibition, we observed a HIF-1a transcriptional activity in
response to increasing concentration of DMOG in HEK293 cells
transfected with pGluc-HRE to (Fig. 3H). Furthermore, we
observed that the transcriptional activity for cells exposed to
100 mM JNJ1935 is much smaller than those exposed to 1 mM
DMOG (Fig. 3I cf. 3H), consistent with the model prediction
(Fig. 3C,D). We also observed a stronger induction of the PHD2
protein [a HIF regulated gene (Metzen et al., 2005)] in hypoxia (1%
O2) and DMOG than in JNJ1935 (supplementary material Fig. S2).
No effect from the DMSO solvent was observed on Gaussia activity
Fig. 3. Effect of prolyl-hydroxylases inhibition by DMOG or JNJ1935 on HIF-1a stabilisation and transcriptional activity. Simulations of the effect of
hydroxylase inhibition on HIF protein stabilisation (A,B) and transcriptional activity (C,D) by PHD and FIH inhibition (A,C) or PHD inhibition alone
(B,D). (E) Representative matched western blots are shown for HIF-1a stabilization in HEK293 cells cultured under hypoxic conditions (1% O2 and 3% O2) or
normoxia under increasing concentrations of DMOG or JNJ1935 after 4, 8 or 12 h (n53). (F,G) Relative HIF-1a protein levels under increasing concentrations of
DMOG and JNJ1935 after 12 h (n53). (H,I) Relative luciferase activity from HEK293 cells transfected with HRE-pGluc plasmid and treated with increasing
concentrations of DMOG (H, n54–7) or JNJ1935 (I, n54–17) after 12 h. AU, arbitrary units; RLU, relative luciferase units.
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(supplementary material Fig. S3). Thus we show that the predictions
can be experimentally validated and our model supports a role for
asparaginyl hydroxylation by FIH as an important step in regulating
the transcriptional activity of stabilised HIF-1a.
Temporal dynamics of hydroxylase inhibition
Next we make predictions for the temporal effects of DMOG and
JNJ1935 on the HIF-1a stabilisation and transcriptional activity.
Both DMOG and JNJ1935 inhibitory efficiencies were chosen to
generate a maximal level of HIF-1a stabilisation, and the model
predicts similar patterns of stabilisation (Fig. 4A). However the
transcriptional activities are predicted to be much less with
JNJ1935 treatment than with DMOG treatment (Fig. 4B).
To test these predictions, we used DMOG and JNJ1935 at a
concentration of 1 mM and 100 mM respectively which produced
similar levels of HIF-1a protein stabilisation (Fig. 3F,G). The
experimental data from HEK293 cells transfected with pGluc-
HRE and treated with DMOG and JNJ1935 over a 12-hour period
matched the predicted outcome (Fig. 4D cf. 4B). Thus we show
that our mathematical model can predict the temporal dynamics
of hydroxylase inhibition by DMOG and JNJ1935 on HIF-1a
transcriptional activity.
Residual activity of FIH in hypoxia
FIH has previously been shown to have higher affinity for oxygen
than PHD (Koivunen et al., 2004; Stolze et al., 2004). Our model
predicts that a reduction in active FIH will result in an increase in
HIF-1a activity (Fig. 5A) while an increase in FIH will cause a
decrease in activity at 1% oxygen (Fig. 5B).
To experimentally test these predictions, we used either siRNA
against FIH (FIH siRNA) or an overexpression plasmid for FIH
(pcDNA3-FIH) in HEK293 cells transfected with pGluc-HRE.
We show that we can manipulate the level of FIH protein
expressed (Fig. 5C). Experimental data in cells exposed to 1%
oxygen confirmed the predictions that that knocking down FIH
increases the HIF-1a activity (Fig. 5D), while overexpressing
FIH decreases the activity (Fig. 5E). No effect was observed
when the experiments were performed in normoxia
(supplementary material Fig. S4).
Role of FIH in hydroxylase regulation of HIF-1a
We next used the model to make predictions about the role of
FIH during PHD inhibition using the pharmacological inhibitor
JNJ1935. Our model simulations predict that, with JNJ1935
treatment, silencing FIH will result in a downregulation of total
HIF-1a stabilisation while at the same time lead to an
upregulation of HIF-1a transcriptional activity (Fig. 6A,B).
This prediction was tested and validated experimentally
(Fig. 6C,D). Thus, from mathematical predictions and
experimental validation, we show that under JNJ1935, siRNA
against FIH causes a reduction in HIF-1a stabilisation and an
increase in HIF-1a transcriptional activity.
Next, we aimed to provide a possible explanation for these
paradoxical observations described in Fig. 6 and identify a likely
molecular mechanism. Given that JNJ1935 inhibits HIF-1a
degradation mediated by PHD at 2 orders of magnitude higher
than DMOG in vitro (Barrett et al., 2011), we assume that any
upregulated prolyl hydroxylases will be inhibited and not
contribute to the observed decrease in HIF-1a stabilisation. We
isolated from the full model a core HIF-1a signalling module
(Fig. 7A) which consists of unhydroxylated and asparaginyl-
hydroxylated HIF-1a in the cytoplasm and in the nucleus (more
details in the Materials and Methods). Prolyl-hydroxylated HIF-
1a is assumed to be absent in the core module (the grey arrows in
Fig. 7A) as the system is under JNJ1935 inhibition. The core
module describes the dynamic transfer between these HIF-1a
moieties and is thus sufficient in studying the qualitative
behaviour of the system under JNJ1935-mediated inhibition.
In order to account for HIF-1a degradation by PHD-
independent mechanisms (Kong et al., 2007; Liu et al., 2007;
Koh et al., 2008), our full model currently assumes that only the
cytoplasmic HIF-1a is subjected to direct protein turnover for
simplicity (Reactions 1 and 2 in Fig. 1, Fig. 7A). To identify
potential factors that may influence the behaviour of the total
Fig. 4. Comparison of the effects of DMOG or JNJ1935 on
HIF-1a stabilisation and transcriptional activity. In silico
predictions and in vitro experimental data from HEK293 cells
transfected with HRE-pGluc plasmid on HIF-1a stabilisation
(A,C) and transcriptional activity (B,D) by DMOG (1 mM,
n57) or JNJ1935 (100 mM, n517) over 12 hours. Ctrl,
control. AU, arbitrary units; RLU, relative luciferase units.
Journal of Cell Science 126 (6)1458
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HIF-1a stabilisation and transcriptional activity in the core
module, we carried out a parameter sensitivity analysis in which
we systematically perturbed each reaction numbered in Fig. 7A
by increasing or decreasing its rate by 10-fold and compare
simulations under JNJ1935 with or without silencing FIH
(supplementary material Figs S6, S7). We then compared the
responses of total HIF-1a stabilisation and transcriptional activity to
that of the unperturbed case. Although the perturbations appeared to
alter the levels of total HIF-1a stabilisation and activity
quantitatively, none of them resulted in a qualitative change.
Specifically, we always observed a reduction of HIF-1a
stabilisation and an increase in HIF-1a transcriptional activity
under reduced FIH under all perturbations, including varying the
HIF-1a abundance, consistent with the data (supplementary material
Figs. S6, S7; Fig. 6). Similar observations were seen even when we
varied the fold change in reaction rates up to 20 (data not shown),
thus suggesting that the perturbed reactions are not essential in
controlling the qualitative behaviour of HIF-1a under FIH silencing.
When we relaxed our assumption of oxygen-independent
degradation and assumed that other forms of HIF-1a (HIF-1an,
HIF-1a-aOH and HIF-1an-aOH) are also susceptible to such
degradation (Reactions 2b–d in Fig. 7A,B), we found that, as long
as the degradation rate of the asparaginyl-hydroxylated HIF-1a (rate
[2c + 2d]) was less than that of the unhydroxylated HIF-1a (rate [2+
2b]), silenced FIH would always lead to decreased HIF-1a
stabilisation (Fig. 7C) but increased HIF-1a activity (Fig. 7D) as
observed in our predictions and our experimental data (Fig. 6). On the
other hand, if the asparaginyl-hydroxylated HIF-1a degraded faster
than unhydroxylated HIF-1a by oxygen-independent mechanisms,
reduced FIH would lead to increased HIF-1a stabilisation (Fig. 7E)
and increased HIF-1a activity (Fig. 7F) instead. Analytical
derivations further confirmed these findings mathematically,
showing they were true regardless of the rate values of other
reactions (see Materials and Methods for detailed derivation). Thus,
analysis of the core signalling module reveals that the differential
rates in PHD-independent degradation of the unhydroxylated HIF-1a
and asparaginyl-hydroxylated HIF-1a directly control the qualitative
response of HIF stabilisation and activity under JNJ1935 inhibition.
Fig. 5. Regulation of HIF-1a transcriptional activity by FIH. In
silico predictions for HIF-1a transcriptional activity in hypoxia (1% O2)
when FIH levels are decreased by 10-fold (A) or overexpressed by 10-
fold (B). (C) Representative western blot showing the expression of FIH
in HEK293 cells used in D and E. (D,E) In vitro data on HIF-1a
transcriptional activity in hypoxia (1% O2) from HEK293 cells
transfected with HRE-pGluc plasmid and either siRNA against FIH
(D, n53–6) or FIH-V5 tag construct (E, n53–6). AU, arbitrary units;
RLU, relative luciferase units.
Fig. 6. Effect of joint FIH inhibition and hydroxylase inhibition on HIF-
1a transcriptional activity. (A,B) In silico predictions on HIF-1a protein
stabilisation and transcriptional activity in normoxia when FIH is decreased
by 10-fold in the presence of JNJ1935. (C) Representative western blot
showing the expression of HIF-1a in HEK293 cells in the presence of
JNJ1935 (100 mM) and transfected with siRNA against FIH. (D) HIF-1a
transcriptional activity in HEK293 cells transfected with HRE-pGluc plasmid
and siRNA against FIH or non-target (NT) siRNA in the presence of JNJ1935
(100 mM). n59 per group. AU, arbitrary units; RLU, relative luciferase
units.
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Importantly, the finding suggests that asparaginyl-hydroxylated HIF-
1a is less prone to degradation by oxygen-independent mechanisms,
resulting in a model that better fits our experimental data.
We next tested the qualitative simulations from the core
module by inhibiting proteosomal degradation in HEK293 cells
transfected with siRNA against FIH and under PHD inhibition
from JNJ1935. The use of MG132 increased the level of HIF-1a
stabilisation (Fig. 7G), thus showing that HIF-1a is susceptible to
proteosomal degradation. Furthermore, we also tested our
simulations on HEK293 cells transfected with a full length
HIF-1a that includes mutations to both proline residues required
for hydroxylation by PHD [Dmut-Pro; (Hagen et al., 2003)] and
siRNA against FIH. This Dmut-Pro HIF-1a is constitutively
stable and can be detected by antibodies against its V5-tag or
against HIF itself. Silencing FIH reduced its expression, and
MG132 could reverse this decrease (Fig. 7H).
Thus, using a core module of the HIF-1a model and
experimental data, we show that the decrease in HIF stabilisation
due to FIH silencing in JNJ1935-treated cells arises from non-PHD
dependent proteosomal degradation of unhydroxylated HIF. Our
data suggests that FIH confers protection to HIF-1a from
proteosomal degradation.
Discussion
Here we provide a data-driven iterative mathematical model
which describes the dynamics of HIF-1a signalling at a detailed
mechanistic level. We validated the model using experimental
data and generated predictions which were subsequently pursued
and validated by experiments. Furthermore, we use the
predictions made by the model, supported by experimental
data, to propose that hydroxylation by FIH confers a degree of
protection to the HIF-1a protein from proteosomal degradation.
Our predictive and adaptive model predicts testable hypothesis
that are in agreement with experimental data, thus confirming the
generally accepted HIF-1a network topology. It is supported by
iterative experimental data on the HIF-1a stabilisation and
transcriptional activity dynamics. The later is a key end point of
the signalling pathway, when genes are switched on in response
to hypoxia. This crucial step has been poorly represented in
previous models due to the limited amount of experimental data.
Our model uses data from the Gaussia luciferase reporter which
provides temporal information on the HIF-1a transcriptional
activity from a population of cells (Bruning et al., 2012).
Furthermore, the use of the pharmacological hydroxylase
inhibitors DMOG and JNJ1935 enabled use to selectively
Fig. 7. Schematic diagram of the core HIF-1a module. (A). The core module is extracted from the full model (shown in Fig. 1) and adapted to describe the
reduced HIF-1a signalling network. Under JNJ1935-induced PHD inhibition, the PHD-mediated degradation of the HIFa moieties is prevented in both the
cytoplasm and nucleus, illustrated by the crossed-out grey arrows. The red arrows indicate the degradation of unhydroxylated HIF-1a and asparaginyl-
hydroxylated HIF-1a induced by oxygen-independent mechanisms. The newly introduced rates are labelled 2b, 2c and 2d for HIFan, HIFa-aOH and HIFan-aOH
respectively. Only nuclear HIF-1a free of asparaginyl hydroxylation is assumed to be transcriptionally active. (B) Simplified schematic of the core module. The
percentage of unhydroxylated HIF-1a is assumed to be less than asparaginyl-hydroxylated HIF-1a when FIH is intact. This distribution is assumed to be reversed
when FIH is silenced. The rate of degradation of total unhydroxylated HIF-1a is [2 + 2b], whereas the degradation rate for asparaginyl-hydroxylated HIF-1a is [2c
+ 2d]. (C–F) Qualitative predictions of the level of total HIF-1a protein stabilisation (C,E) and HIF-1a activity (D,F) when the degradation rate for total HIF-1a-
aOH is greater (C,D) or less (E,F) than the degradation rate for total HIF-1a. The curves have been rescaled so that the level of HIF-1a stabilisation or activity at
12 hr for JNJ1935 + FIH intact (solid curves) is 1. (G) Representative western blot showing the effect of the proteosomal inhibitor MG132 (5 mM) on the
expression of HIF-1a in the presence or absence of siRNA against FIH (siFIH) (n53 each). (H) Representative western blot showing the effect of MG132 on the
expression of a HIF-1a construct where both proline residues for PHD hydroxylation are mutated (Dmut-Pro) in the presence or absence of siRNA against FIH
(n54 each). Dmut-Pro was detected using either an antibody against V5 tag or against HIF-1a.
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dissect out the role of PHDs and FIH. Importantly, we show that
HIF-1a stabilisation does not directly correlate to HIF-1a
transcriptional activity due to the inhibitory activity of FIH.
Our model also includes a negative feedback loop through the
upregulation of PHD by HIF-1a (Stiehl et al., 2006) to reflect the
decrease in HIF-1a protein observed after 6–8 hours in hypoxia.
The miR-155 negative feedback loop was not considered in this
model as this is proposed to occur during prolonged hypoxia
(Bruning et al., 2011). Our model assumes that only an
unhydroxylated form of HIF-1a can be transcriptionally active
as prolyl-hydroxylation will result in rapid VHL-mediated
degradation (Chan et al., 2005) and asparaginyl-hydroxylation
will prevent binding of the transcriptional co-activators p300 and
the CREB binding protein (CBP) (Ebert and Bunn, 1998; Lando
et al., 2002). Our data also supports theses assumptions, because
we observe that the HIF-1a transcriptional activity is more
reduced in the presence of JNJ1935 (which inhibits only PHDs)
than in the presence of the pan-hydroxylase inhibitor DMOG.
Inhibition of FIH increases HIF-1a transcriptional activity in
hypoxia while exogenous delivery of FIH reduces it, thus confirming
the role of FIH in controlling the HIF-1a transcriptional response.
Moreover, silencing FIH during inhibition of prolyl-hydroxylation
reduces HIF-1a protein stabilisation but paradoxically increases HIF-
1a transcriptional activity, for which we propose a novel role for FIH
in conferring protection from non-PHD-mediated degradation. A
possible explanation for the observed decrease in HIF-1a stabilisation
could be the negative feedback upregulation of PHD enzymes.
However this is unlikely as the cells were incubated in JNJ1935,
which would inhibit any upregulated prolyl hydroxylases, given that
its potency is of 2 orders of magnitude over DMOG (Barrett et al.,
2011). Furthermore, we can also observe this FIH-mediated
protection from proteosomal degradation using HEK293 cells
transfected with a HIF-1a construct where both its proline residues
for PHD hydroxylation were mutated (Hagen et al., 2003).
Furthermore, the proteosomal inhibitor MG132 reversed the
decrease in HIF stabilisation, indicating the decrease is at the
protein level.
Thus we have a counter-intuitive observation: both the model
and the experimental data show that a decrease in HIF-1a protein
occurs parallel to an increase in HIF-1a activity when the PHD
enzymes are inhibited and when FIH is silenced. A comparable
decrease in HIF-1a protein stabilisation was observed in HeLa
and U-2OS cells exposed to hypoxia and transfected with siRNA
against FIH (Stolze et al., 2004), which was explained through
upregulation of PHD2 via FIH activity. In our study, we go
further and explore the effect of FIH activity in an environment
where PHD enzymes are inhibited with JNJ1935 (Barrett et al.,
2011). Through parameter sensitivity analysis, we have narrowed
down the reactions to the degradation rate of unhydroxylated and
asparaginyl-hydroxylated HIF-1a protein. Using a reduced core
model, we show that our model simulation can match the
experimental observation only if the rate of degradation of
unhydroxylated HIF-1a protein is higher than the rate of
degradation of asparaginyl-hydroxylated HIF-1a. We also
provide mathematical proof that this is the most likely
explanation. We propose that loss of FIH makes it more
susceptible for HIF-1a to be degraded via non-PHD-mediated
degradation. The most likely explanation is that asparaginyl-
hydroxylation confers protection to this degradation. We speculate
that the asparaginyl-hydroxyl residue on HIF-1a might be
interfering a non-PHD-mediated degradation mechanism, of
which several have been proposed, such as RACK1 (Liu et al.,
2007), COMMD1 (van de Sluis et al., 2009) and DEC2/SHARP1
(Montagner et al., 2012) dependent degradation. It is probably not
dependent on the interaction of FIH to VHL (Mahon et al., 2001),
as VHL was not necessary for non-PHD degradation (Kong et al.,
2007; Liu et al., 2007; Koh et al., 2008; van de Sluis et al., 2009).
In summary, our study illustrates how biological experiments
coupled to mathematical modelling can synergize to provide a
better understanding of a complex signalling pathway. The
process is iterative and incremental; leading to a robust predictive
and adaptive model whose predictions can be tested
experimentally. Our in vitro data and in silico predictions
provide new insights into the molecular mechanisms linking
hypoxia to gene expression. Specifically, we propose that non-
PHD-mediated degradation is an important step in controlling the
HIF-1a response during hypoxia, and that FIH confers protection
from this degradation mechanism.
Materials and Methods
Cell culture
Human embryonic kidney cells (HEK293) were cultured in DMEM high-glucose
medium supplemented with 10% FCS and 100 U/ml penicillin-streptomycin. Human
hepatocellular carcinoma cells (HepG2) were grown in minimum essential medium
containing 10% FCS, 2 mML-glutamine, non-essential amino acids, and 100 U/ml of
penicillin-streptomycin. Cells were exposed to hypoxia using pre-equilibrated media
and maintained in standard normobaric hypoxic conditions (1% or 3% O2, 5% CO2
and 94% or 92% N2) in a hypoxia chamber (Coy Laboratories, Grass Lake, Michigan,
USA). Normoxic controls were exposed to pre-equilibrated normoxic media and
maintained at atmospheric O2 levels (21% O2, 5% CO2) in a tissue culture incubator.
Western blot analysis
Whole-cell extracts were generated in either normoxia or hypoxia according to
previously published protocol (Agbor et al., 2011). Protein concentration was
quantified using a Lowry assay (Bio-Rad, Hertfordshire, UK), and samples were
normalised accordingly. Samples were separated by SDS-PAGE and immunoblotted
as described previously (Bruning et al., 2011) using the following primary antibodies
and dilutions: HIF-1a (1:250; BD Pharmingen, Oxford, UK), PHD1 (1:1000, Novus
Biological, Cambridge, UK), PHD2 (1:1000, Novus Biological, Cambridge, UK),
PHD3 (1:1000, Novus Biological, Cambridge, UK), FIH (1:2000, Abcam,
Cambridge, UK) and b-actin (1:10,000; Sigma, Wicklow, Ireland).
Transient transfections and Gaussia luciferase assay
All transfection was performed using Lipofectamine 2000 (Invitrogen, Paisley, UK)
according to the manufacturer’s protocol. A custom FIH siRNA (Eurofins MWG
Operon, Ebersberg, Germany) using published sequence (F1) (Cockman et al., 2006)
was used to downregulate FIH expression. A pcDNA3-FIH-V5 tag construct (kind gift
of Prof Eric Metzen, University of Duisburg-Essen) was used to overexpress FIH.
Confirmation of knockdown or overexpression was obtained by immunoblotting for
FIH protein. A full length HIF-1a construct with mutations at both proline residues
required for hydroxylation by PHD (pcDNA3-HIF-DM-Pro-V5 tag, abbreviated to
Dmut-Pro, kind gift of Prof Thilo Hagen, National University of Singapore). The
pGluc-HRE Gaussia luciferase vector (containing four copies of the EPO HREs in the
right orientation) was transfected into HEK293 cells as previously described (Bruning
et al., 2012). The mammalian expression vector pGluc-TK (NEB) contains the coding
sequence for Gaussia luciferase under the control of the Herpes Simplex Virus
thymidine kinase (TK) promoter for constitutive activity. It does not contain the EPO
HRE sequence. Gaussia luciferase activity was measured using the Biolux Gaussia
luciferase Flex Assay kit (NEB, Hertfordshire, UK) in a plate reader (Synergy HT,
Biotek, Bedfordshire, UK).
Reagents
The cell permeable pan-hydroxylase inhibitor DMOG (Cayman Chemicals,
Michigan, USA), the prolyl-hydroxylase inhibitor JNJ-42041935 [abbreviated to
JNJ1935 in this paper; kind gift of Dr Mike Rabinowitz (Janssen Research &
Development, LLC)] and the proteosomal inhibitor MG132 (Sigma, Wicklow,
Ireland) were dissolved in DMSO (DMSO; Sigma, Wicklow, Ireland).
Model calibration and parameter selection
As many of the kinetic parameters in the HIF/PHD/FIH system are not measured at
the present time, we needed to estimate unknown model parameters using a total of
six experimental data sets. These include HIF stabilisation data under DMOG and
JNJ1935 hydroxylase inhibitors, and transcriptional activity data under DMOG,
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JNJ1935, 1% and 3% oxygen tension, which constrained the model parameters
well. Knowledge of the rate constants of reactions and initial concentrations of
model species were required to describe the temporal (and steady-state) behaviours
of the system. Where possible, estimates for model parameters were obtained from
the literature (supplementary material Table S3). In the absence of such
information, the kinetic rate constants and initial concentrations were set to
intermediate values within physiologically plausible ranges before fitting so as to
optimise model performance. Specifically, the association and dissociation rates
were restricted to be within the typical ranges for protein-protein interactions. The
association of protein molecules into dimers or larger complexes occurs with
typical rate constants of the order of 1024 to 1021 nM21 s21 (Eltis et al., 1991;
Northrup and Erickson, 1992; Kholodenko et al., 1999). In addition, the reaction
rates were always constrained not to be faster than the diffusion limit. The fitted
parameter set is given in supplementary material Table S3. Although parameter
fitting constitutes an important step in model development, it is worthwhile to note
that the prime purpose of computational modelling is to provide a basis for guiding
experimental analysis and testing explicit hypotheses; a model by itself is not an
objective ‘truth’, but it can be used to falsify or confirm a specific hypothesis.
Step function to simulate hypoxia induction and inhibitor experiments
For realistic simulations of the hypoxia and inhibitors experiments, we employed
the step function, which can be used to describe the sudden depletion of either
oxygen level or PHD and/or FIH levels due to the inhibitors (DMOG and JNJ1935)
while the system is in normoxia condition prior to the start of the experiments.
Specifically, for simulations describing hypoxia at 3% oxygen tension, we
define the following function:
Hypo3(t)~O2
: 1{
18
21
StepFunction(t{tstart)
 
where StepFunction(t) is the fundamental unit-step function which equals 0 for
t,0 and 1 for t>0, and tstart is the time at which the experiment starts. Hypo3(t)
then represents the level of oxygen throughout the experiment, which is reduced to
only 3/21 that of the normoxia oxygen level (supplementary material Fig. S5).
Similarly, we define Hypo1(t) for experiments at 1% oxygen tension as:
Hypo1(t)~O2: 1{
20
21
StepFunction(t{tstart)
 
As a result, O2 is replaced by Hypo3(t) or Hypo1(t) in the reaction rates v3, v9
and v11 in supplementary material Table S1 to describe a model for 3% and 1%
oxygen tension, respectively.
To model experiments using inhibitors, we assume that DMOG efficiently
reduces both PHD and FIH levels to very low level (1% of the abundance of active
enzymes prior to treatment) and that JNJ1935 reduces PHD to low level (10% of
its pre-treated level) while FIH is slightly affected (reduced to 80% of its pre-
treated level (Barrett et al., 2011). siRNA and overexpression experiments were
modelled by adjusting the initial value of a species (FIH for example) to the
measured extent of protein depletion or protein overexpression as determined by
quantitative western blotting.
Analysis of the core HIF-1a signalling module
Here we consider the core module of the HIF signaling network extracted from the
full model as explained in the main text. This reduced model retains the essential
features of the HIF-1a dynamic signaling under JNJ1935 where PHD-mediated
degradation of HIF-1a is prevented due to PHD inhibition. Thus, the reduced
model can be used to analyse the dynamical properties of HIF-1a signalling under
this particular inhibitor. In addition to simulations, we present the analytical
derivation showing that the differential rates in oxygen-independent degradation of
the unhydroxylated HIF-1a and asparaginyl–hydroxylated HIF-1a directly control
the qualitative response of HIF stabilization and activity under JNJ1935 inhibition.
Following the reactions of the schematic diagram of the core module given in Fig. 7A
when all forms of HIF-1a are subjected to degradation, the ordinary differential
equations (ODE) governing the dynamics of the core HIF-1a module is given below:
dHIFa
dt
~v1{v2{v9zv10{v5zv6
dHIFan
dt
~v9{v10{v17zv18{v2b
dHIFa-aOH
dt
~v5{v6{v13zv14{v2c
dHIFan-aOH
dt
~v13{v14zv17{v18{v2d
where vi are the rates of the corresponding reactions, as described in supplementary
material Table S1.
We have HIFtot~HIFazHIFanzHIFa-aOHzHIFan-aOH is the total HIF
stabilisation. The dynamics of this total HIF can be obtained by summing up the
left and right hand sides of the above systems of ODEs:
dHIFtot
dt
~v1{v2{v2b{v2c{v2d
Assuming the oxygen-independent degradation of the HIF forms follow the
first-order kinetics and that the degradation rates of HIFa (k2) and HIFa-aOH (k2*)
are independent of localisation (identical in cytoplasm or nucleus), the above ODE
can be rewritten as follows
dHIFtot
dt
~v1{k2 HIFazHIFanð Þ{k2 HIFa-aOHzHIFan-aOHð Þ
~v1{k2 HIFazHIFanð Þ{k2 HIFtot-HIFa-HIFanð Þ
~v1{k2HIFtotz k

2{k2
 
HIFazHIFanð Þ
ð1Þ
Now, consider three scenarios:
(i) k25k2*: degradation rate [HIFa]total5degradation rate [HIFa-aOH]total
In this case, Eqn (1) becomes:
dHIFtot
dt
~v1{k2HIFtot~k1{k2HIFtot
Since the right-hand side of Eqn 1 depends only on HIFtot, HIFtot is not affected
by change in any parameters other than k1 and k2. As a result, silencing FIH by
reducing both FIH and FIHn would not change the total HIF stabilisation but
increase HIF activity due to more HIFan are available, as illustrated in
supplementary material Fig. S8.
(ii) Finally k2.k2*: degradation rate [HIFa]total .degradation rate [HIFa-
aOH]total
In this case, the last term of Eqn 1 is negative. When FIH is silenced, the sum
(HIFa + HIFan) is increased, but in contrast to case (ii) this makes the right-hand
side of Eqn 1 smaller due to the negative factor (k2’ 2 k2) and so the total HIF
stabilisation is decreased. This can be seen in the simulation given in Fig. 7C,D.
(iii) Finally k2,k2*: degradation rate [HIFa]total,degradation rate [HIFa-
aOH]total
In this case, the last term of Eqn (1) is positive. When FIH is silenced, less HIFa
and HIFan are converted into HIFa-aOH and HIFan-aOH, thereby increasing the
sum (HIFa + HIFan), making the right-hand side of Eqn 1 bigger and so increasing
the total HIF stabilisation. Moreover, since HIFan is larger, HIF activity increases.
This can be seen in the simulation given in Fig. 7E,F.
Statistical analysis
All experiments were carried out a minimum of n53 independent times unless
otherwise indicated and data are expressed as the mean6s.e.m. Statistical
significance was calculated by one-way ANOVA followed by Bonferroni’s
multiple comparison test in Prism (GraphPad, California, USA).
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